Finance

Lists
Why is SDZNY up 3.21%?
Dive Deeper
SDZNY:OTCMKTS
SANDOZ GROUP ADR
$ 91.04
+3.21%
(+2.83) 1D
10-р сарын 15, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SDZNY...
Open
$ 89.99
High
$ 91.34
Low
$ 89.95
Mkt. cap
33.11 тэрбум
Avg. vol.
26.84 мян
Volume
28.60 мян
52-wk high
$ 94.15
52-wk low
$ 60.40
Shares outstanding
440.00 сая
No. of employees
20 мян
Open
$ 89.99
High
$ 91.34
Low
$ 89.95
Mkt. cap
33.11 тэрбум
Avg. vol.
26.84 мян
Volume
28.60 мян
52-wk high
$ 94.15
52-wk low
$ 60.40
Shares outstanding
440.00 сая
No. of employees
20 мян
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
2 цагийн өмнө
Sandoz stock pre-market at EUR 81.94
ad-hoc-news.de
ad-hoc-news.de
·
22 цагийн өмнө
Barclays keeps CHF 93.00 target for Sandoz stock
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About SANDOZ GROUP ADR
CEORichard Saynor
Employees20 мян
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.95 тэрбум
2.95 тэрбум
2.89 тэрбум
2.89 тэрбум
Cost of goods sold
1.50 тэрбум
1.50 тэрбум
1.52 тэрбум
1.52 тэрбум
Cost of revenue
1.50 тэрбум
1.50 тэрбум
1.52 тэрбум
1.52 тэрбум
Research and development expenses
272.00 сая
272.00 сая
253.50 сая
253.50 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
668.50 сая
668.50 сая
680.00 сая
680.00 сая
Operating expense
1.02 тэрбум
1.02 тэрбум
1.23 тэрбум
1.23 тэрбум
Total operating expenses
2.52 тэрбум
2.52 тэрбум
2.74 тэрбум
2.74 тэрбум
Operating income
421.50 сая
421.50 сая
151.50 сая
151.50 сая
Other non operating income
-28.00 сая
-28.00 сая
-
-
EBT including unusual items
351.50 сая
351.50 сая
69.00 сая
69.00 сая
EBT excluding unusual items
367.50 сая
367.50 сая
97.50 сая
97.50 сая
Income tax expense
83.00 сая
83.00 сая
14.50 сая
14.50 сая
Effective tax rate
23.61%
23.61%
21.01%
21.01%
Other operating expenses
82.50 сая
82.50 сая
292.00 сая
292.00 сая
Net income
268.50 сая
268.50 сая
54.50 сая
54.50 сая
Net profit margin
9.11%
9.11%
1.88%
1.88%
Earnings per share
-
-
-
-
Interest and investment income
23.50 сая
23.50 сая
-
-
Interest expense
-54.50 сая
-54.50 сая
-54.00 сая
-54.00 сая
Net interest expenses
-31.00 сая
-31.00 сая
-54.00 сая
-54.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
531.00 сая
531.00 сая
284.50 сая
284.50 сая
Gain or loss from assets sale
-3.00 сая
-3.00 сая
-16.00 сая
-16.00 сая
AI content may include mistakes. Learn more
Google аппс